We are live on ! Find out more

2,056 hedge funds and large institutions have $142B invested in Merck in 2018 Q3 according to their latest regulatory filings, with 117 funds opening new positions, 756 increasing their positions, 900 reducing their positions, and 61 closing their positions.

New
Increased
Maintained
Reduced
Closed

92% more first-time investments, than exits

New positions opened: 117 | Existing positions closed: 61

25% more call options, than puts

Call options by funds: $1.4B | Put options by funds: $1.12B

24% more funds holding in top 10

Funds holding in top 10: 115143 (+28)

18% more capital invested

Capital invested by funds: $120B → $142B (+$21.5B)

2% more funds holding

Funds holding: 2,0172,056 (+39)

1.27% more ownership

Funds ownership: 77.38%78.66% (+1.3%)

16% less repeat investments, than reductions

Existing positions increased: 756 | Existing positions reduced: 900

Holders
2,056
Holders Change
+39
Holders Change %
+1.93%
% of All Funds
47.01%
Holding in Top 10
143
Holding in Top 10 Change
+28
Holding in Top 10 Change %
+24.35%
% of All Funds
3.27%
New
117
Increased
756
Reduced
900
Closed
61
Calls
$1.4B
Puts
$1.12B
Net Calls
+$284M
Net Calls Change
+$173M
Name Holding Trade Value Shares
Change
Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$14.4B +$61.7M +969,087 +0.5%
BlackRock
2
BlackRock
New York
$13.1B -$85M -1,334,002 -0.7%
State Street
3
State Street
Massachusetts
$8.01B +$231M +3,622,256 +3%
Capital World Investors
4
Capital World Investors
California
$6.19B -$1.18B -18,542,786 -17%
Wellington Management Group
5
Wellington Management Group
Massachusetts
$4.99B -$269M -4,214,884 -5%
T. Rowe Price Associates
6
T. Rowe Price Associates
Maryland
$3.57B +$512M +8,031,751 +18%
Bank of America
7
Bank of America
North Carolina
$3.14B +$119M +1,871,589 +4%
JP Morgan Chase
8
JP Morgan Chase
New York
$3.12B -$64.9M -1,019,296 -2%
Franklin Resources
9
Franklin Resources
California
$2.86B -$316M -4,962,421 -11%
Bank of New York Mellon
10
Bank of New York Mellon
New York
$2.77B +$20.8M +325,766 +0.8%
Capital International Investors
11
Capital International Investors
California
$2.34B +$1.41B +22,142,025 +178%
Northern Trust
12
Northern Trust
Illinois
$2.24B -$71.1M -1,115,397 -3%
Geode Capital Management
13
Geode Capital Management
Massachusetts
$2.18B +$7.47M +117,197 +0.4%
Norges Bank
14
Norges Bank
Norway
$2.04B -$11.2M -175,494 -0.6%
Deutsche Bank
15
Deutsche Bank
Germany
$1.75B -$137M -2,152,829 -8%
Wells Fargo
16
Wells Fargo
California
$1.67B -$102M -1,601,867 -6%
Invesco
17
Invesco
Georgia
$1.46B +$3.87M +60,755 +0.3%
Janus Henderson Group
18
Janus Henderson Group
United Kingdom
$1.46B +$536M +8,418,200 +64%
Morgan Stanley
19
Morgan Stanley
New York
$1.18B +$44.1M +692,903 +4%
State Farm Mutual Automobile Insurance
20
State Farm Mutual Automobile Insurance
Illinois
$1.07B
Goldman Sachs
21
Goldman Sachs
New York
$1.03B -$142M -2,235,852 -13%
Ameriprise
22
Ameriprise
Minnesota
$1.01B +$16.9M +264,708 +2%
TCIM
23
TIAA CREF Investment Management
New York
$991M +$201M +3,161,420 +28%
Macquarie Group
24
Macquarie Group
Australia
$982M -$59.3M -931,098 -6%
Boston Partners
25
Boston Partners
Massachusetts
$952M -$75.8M -1,189,790 -8%

MRK Hedge Fund Activity: Q3 2018 in Review

2,056 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q3 2018, worth a combined $142B — up 18% from $120B a quarter earlier.

Buyers outnumbered sellers: 117 funds opened new MRK positions and 61 closed out — a net gain of 56 holders — while 756 added to existing stakes and 900 trimmed.

The largest buyer was Capital International Investors, adding an estimated $1.41B. The largest seller was Capital World Investors, cutting an estimated $1.18B.

  • 2,056 institutional investors held Merck (MRK) as of Q3 2018, up from 2,017 in Q2 2018.
  • Funds reported $142B of Merck stock for Q3 2018, up 18% quarter-over-quarter.
  • 117 funds opened new Merck positions in Q3 2018 and 61 closed out, a net change of +56 holders.
  • The largest Merck buyer in Q3 2018 was Capital International Investors, an estimated $1.41B added.
  • The largest Merck seller in Q3 2018 was Capital World Investors, an estimated $1.18B sold.

Based on aggregated 13F filings for Q3 2018.